One of the therapeutic targets that has gained prominence in recent years is HAT1, whose overexpression is known to be related to the development of various pathologies, such as infections caused by viruses (HBV, HIV, and COVID-19) [18,26,27,44] or cancer. Here, HAT1 is linked to infection.